共 123 条
[1]
Jansen PL(2009)EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 237-67
[2]
Ghallab A(2017)The ascending pathophysiology of cholestatic liver disease Hepatology 65 722-38
[3]
Vartak N(2017)New therapeutic concepts in bile acid transport and signaling for management of cholestasis Hepatology 65 1393-404
[4]
Reif R(2018)Drug-induced cholestasis: mechanisms, models, and markers Curr Drug Metab 19 808-18
[5]
Schaap FG(2018)Clinical guidelines for primary sclerosing cholangitis 2017 J Gastroenterol 53 1006-34
[6]
Hampe J(2017)EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis J Hepatol 67 145-72
[7]
Trauner M(2000)Cloning, mapping and expression analysis of VPS33B, the human orthologue of rat Vps33b Cytogenet Cell Genet 89 92-5
[8]
Fuchs CD(2017)Vps33b is crucial for structural and functional hepatocyte polarity J Hepatol 66 1001-11
[9]
Halilbasic E(2004)Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome Nat Genet 36 400-4
[10]
Paumgartner G(2009)Clinical characteristics and VPS33B mutations in patients with ARC syndrome J Pediatr Gastroenterol Nutr 48 348-54